1. Home
  2. OLED vs CORT Comparison

OLED vs CORT Comparison

Compare OLED & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OLED

Universal Display Corporation

HOLD

Current Price

$92.28

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$58.36

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLED
CORT
Founded
1985
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.7B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
OLED
CORT
Price
$92.28
$58.36
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$125.00
$96.50
AVG Volume (30 Days)
1.0M
1.0M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
2.23%
N/A
EPS Growth
9.25
N/A
EPS
0.76
N/A
Revenue
$650,611,000.00
$761,407,000.00
Revenue This Year
$5.88
$26.08
Revenue Next Year
$10.36
$26.98
P/E Ratio
$119.58
N/A
Revenue Growth
0.45
12.79
52 Week Low
$83.64
$28.66
52 Week High
$163.20
$91.00

Technical Indicators

Market Signals
Indicator
OLED
CORT
Relative Strength Index (RSI) 44.81 80.26
Support Level $85.04 $32.95
Resistance Level $100.42 $90.00
Average True Range (ATR) 4.79 2.24
MACD -0.25 0.57
Stochastic Oscillator 48.07 93.81

Price Performance

Historical Comparison
OLED
CORT

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. The large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: